CompletedPhase 2NCT04339712
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
Studying Macrophage activation syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Principal Investigator
- Apostolos Armaganidis, MD, PhDNational Kapodistrian University of Athens, Medical School
- Intervention
- Anakinra(drug)
- Enrollment
- 102 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2021
Study locations (17)
- 2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens, Haidari, Greece
- Intensive Care Unit, Ioannina University Hospital, Ioannina, Ioannina, Greece
- Department of Internal Medicine, Patras University Hospital, Pátrai, Rion, Greece
- Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece
- Intensive Care Unit, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece
- 1st Department of Pulmonary Medicine and Intensive Care Unit, Athens, Greece
- Intensive Care Unit, General Hospital of Athens IPPOKRATEIO, Athens, Greece
- 4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece
- Intensive Care Unit, General Hospital ASKLEPIEIO Voulas, Athens, Greece
- Intensive Care Unit, "Latsio", Thriasio Elefsis General Hospital, Elefsina, Greece
- Intensive Care Unit, "Koutlimbaneio & Triantafylleio" Larissa General Hospital, Larissa, Greece
- Department of Internal Medicine, Larissa University Hospital, Larissa, Greece
- Intensive Care Unit, AGIOS DIMITRIOS General Hospital of Thessaloniki, Thessaloniki, Greece
- Intensive Care Unit, G. GENNIMATAS General Hospital of Thessaloniki, Thessaloniki, Greece
- Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, Thessaloniki, Greece
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04339712 on ClinicalTrials.gov